Sulfonamides Market , By Product Type (Sulfadiazine, Sulfamethoxazole, Sulfasalazine, Sulfisoxazole, Sulfathiazole, Sulfapyridine, Sulfacetamide, and Others (fixed-dose sulfonamide combinations)), By Route of Administration (Oral, Parenteral, and Topical), By Application (Urinary tract infections, Respiratory tract infections, Gastrointestinal infections, Ophthalmic infections, Skin and soft-tissue infections, HIV-associated opportunistic infections, and Veterinary infections), By Class (Short-acting sulfonamides, Intermediate-acting sulfonamides, Long-acting sulfonamides, and Combination sulfonamides (TMP-SMX) ), By Formulation (Tablets, Capsules, Suspensions, Injectables, Ointments and creams, and Ophthalmic solutions), By Prescription Type (Prescription-Based and Over-the-Counter (OTC)), By Status (Branded/Patented Drugs and Generic Drugs), By End User (Hospitals, Clinics, and Veterinary hospitals and clinics), By Distribution Channel (Hospital pharmacies, Retail pharmacies, and Online pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, Africa)